HomeCompareVINE vs JNJ

VINE vs JNJ: Dividend Comparison 2026

VINE yields 347.83% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VINE wins by $4191.69M in total portfolio value
10 years
VINE
VINE
● Live price
347.83%
Share price
$0.58
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4191.71M
Annual income
$2,677,457,066.40
Full VINE calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — VINE vs JNJ

📍 VINE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVINEJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VINE + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VINE pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VINE
Annual income on $10K today (after 15% tax)
$29,565.22/yr
After 10yr DRIP, annual income (after tax)
$2,275,838,506.44/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, VINE beats the other by $2,275,837,802.83/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VINE + JNJ for your $10,000?

VINE: 50%JNJ: 50%
100% JNJ50/50100% VINE
Portfolio after 10yr
$2095.86M
Annual income
$1,338,728,947.09/yr
Blended yield
63.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VINE
No analyst data
Altman Z
-1.0
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VINE buys
0
JNJ buys
0
No recent congressional trades found for VINE or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVINEJNJ
Forward yield347.83%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$4191.71M$20.0K
Annual income after 10y$2,677,457,066.40$827.78
Total dividends collected$4046.69M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VINE vs JNJ ($10,000, DRIP)

YearVINE PortfolioVINE Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$45,483$34,782.61$10,676$355.77+$34.8KVINE
2$196,517$147,850.82$11,407$389.39+$185.1KVINE
3$807,302$597,028.67$12,198$426.53+$795.1KVINE
4$3,155,984$2,292,170.37$13,056$467.62+$3.14MVINE
5$11,751,458$8,374,555.78$13,987$513.12+$11.74MVINE
6$41,717,112$29,143,051.52$14,998$563.56+$41.70MVINE
7$141,325,564$96,688,254.17$16,098$619.52+$141.31MVINE
8$457,341,687$306,123,333.58$17,295$681.69+$457.32MVINE
9$1,415,188,738$925,833,132.77$18,599$750.82+$1415.17MVINE
10$4,191,709,016$2,677,457,066.40$20,022$827.78+$4191.69MVINE

VINE vs JNJ: Complete Analysis 2026

VINEStock

Fresh Vine Wine, Inc. produces and sells low-carb and low-calorie wines in the United States and Puerto Rico. Its wine varietals include cabernet sauvignon, pinot noir, chardonnay, and rose. The company offers its products through wholesale, retail, and direct-to-consumer channels. Fresh Vine Wine, Inc. was founded in 2019 and is based in Plymouth, Minnesota.

Full VINE Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this VINE vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VINE vs SCHDVINE vs JEPIVINE vs OVINE vs KOVINE vs MAINVINE vs ABBVVINE vs MRKVINE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.